Optime Care 1 Articles June 21, 2022 People With Rare Diseases Face Challenges, Require Support In the U.S., orphan diseases are conditions impacting fewer than 200,000 people. There are more…Read More
Optime Care 0 Articles June 20, 2022 The win-win-win of the patient-first model Tiffany Burt President and Chief Operating Officer Optime Care Imagine you’ve just been diagnosed with…Read More
Optime Care 0 Articles May 26, 2022 3 Ways The Patient-First Strategy Simplifies Regulatory Compliance Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care The FDA establishes strict…Read More
Optime Care 0 Articles May 16, 2022 Overcoming Complexity By Choosing an All-Inclusive, Patient-First Specialty Pharmacy Solution Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care Specialty Pharmacy Service…Read More
Optime Care 0 Articles April 29, 2022 Conquering the Data Disconnect in Rare and Orphan Drugs Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care With the right data…Read More
Optime Care 0 Articles April 22, 2022 The “Sticky” Revenue Strategy for Rare and Orphan Drugs Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care The patient-first service model…Read More
Optime Care 0 Articles April 15, 2022 The Patient-First Strategy for Cell and Gene Therapies Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care Reengineering cells, repairing or…Read More
Optime Care 0 Articles April 11, 2022 Patient-First Strategy Optimizes Diagnostic Journey, Improves Experience for Rare Disease Patients For many people living with an undiagnosed medical condition, the journey to an official diagnosis…Read More
Optime Care 0 Articles April 11, 2022 Telehealth as a Permanent Option in Specialty Pharmacy Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care From crisis comes opportunity—if…Read More
Optime Care 0 Articles April 4, 2022 The Future of Clinical Trials in the World of Rare Disease The advent of more flexible clinical trial design brings a promise of greater hope in…Read More